12-753541-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_213655.5(WNK1):​c.-25C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00906 in 1,611,392 control chromosomes in the GnomAD database, including 81 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0067 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0093 ( 75 hom. )

Consequence

WNK1
NM_213655.5 5_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.616

Publications

2 publications found
Variant links:
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • pseudohypoaldosteronism type 2C
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0067 (1020/152314) while in subpopulation NFE AF = 0.00992 (675/68026). AF 95% confidence interval is 0.0093. There are 6 homozygotes in GnomAd4. There are 498 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNK1NM_213655.5 linkc.-25C>G 5_prime_UTR_variant Exon 1 of 28 ENST00000340908.9 NP_998820.3 Q9H4A3-5
WNK1NM_018979.4 linkc.-25C>G 5_prime_UTR_variant Exon 1 of 28 ENST00000315939.11 NP_061852.3 Q9H4A3-1A5D8Z4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNK1ENST00000340908.9 linkc.-25C>G 5_prime_UTR_variant Exon 1 of 28 5 NM_213655.5 ENSP00000341292.5 Q9H4A3-5
WNK1ENST00000315939.11 linkc.-25C>G 5_prime_UTR_variant Exon 1 of 28 1 NM_018979.4 ENSP00000313059.6 Q9H4A3-1

Frequencies

GnomAD3 genomes
AF:
0.00670
AC:
1020
AN:
152196
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.0187
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00992
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00753
AC:
1799
AN:
238868
AF XY:
0.00752
show subpopulations
Gnomad AFR exome
AF:
0.00152
Gnomad AMR exome
AF:
0.00271
Gnomad ASJ exome
AF:
0.000615
Gnomad EAS exome
AF:
0.0000555
Gnomad FIN exome
AF:
0.0178
Gnomad NFE exome
AF:
0.0118
Gnomad OTH exome
AF:
0.00630
GnomAD4 exome
AF:
0.00931
AC:
13578
AN:
1459078
Hom.:
75
Cov.:
32
AF XY:
0.00898
AC XY:
6518
AN XY:
725782
show subpopulations
African (AFR)
AF:
0.00141
AC:
47
AN:
33434
American (AMR)
AF:
0.00262
AC:
117
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.000766
AC:
20
AN:
26112
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39680
South Asian (SAS)
AF:
0.00118
AC:
102
AN:
86194
European-Finnish (FIN)
AF:
0.0178
AC:
926
AN:
51882
Middle Eastern (MID)
AF:
0.000592
AC:
3
AN:
5064
European-Non Finnish (NFE)
AF:
0.0107
AC:
11890
AN:
1111740
Other (OTH)
AF:
0.00783
AC:
472
AN:
60266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
712
1423
2135
2846
3558
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
432
864
1296
1728
2160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00670
AC:
1020
AN:
152314
Hom.:
6
Cov.:
33
AF XY:
0.00669
AC XY:
498
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00156
AC:
65
AN:
41578
American (AMR)
AF:
0.00274
AC:
42
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4832
European-Finnish (FIN)
AF:
0.0187
AC:
198
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00992
AC:
675
AN:
68026
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
60
120
180
240
300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00293
Hom.:
0
Bravo
AF:
0.00556
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 14, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pseudohypoaldosteronism type 2C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
16
DANN
Benign
0.61
PhyloP100
0.62
PromoterAI
-0.0012
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=298/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72647367; hg19: chr12-862707; API